Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Association of the CHEK2 c. 1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival

Cancer Medicine(2023)10.1002/cam4.6272Source: DataRank Database

Association of the CHEK2 c. 1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival is a research paper published in Cancer Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (74 grants)Impact (FWCI 2.17)OA: goldTopics (33)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (100)

Maartje A. C. Schreurs ORCID,Irene L. Andrulis ORCID,Hoda Anton‐Culver ORCID,Annelie Augustinsson ORCID,Matthias W. Beckmann ORCID

Live enrichment

PubMed:37401034 PMC:PMC10469654 OpenAlex:https://openalex.org/W4383058646

Canadian Institutes of Health Research

Grant: GPH‐129344

Cancer Research UK

Grant: C12292/A11174

Cancer Research UK

Grant: C1281/A12014

Cancer Research UK

Grant: C1287/A10118

Cancer Research UK

Grant: C1287/A10710

Cancer Research UK

Grant: C1287/A16563

Cancer Research UK

Grant: C5047/A10692

Cancer Research UK

Grant: C5047/A15007

Cancer Research UK

Grant: C5047/A8384

Cancer Research UK

Grant: C8197/A16565

FP7 Ideas: European Research Council

Grant: HEALTH‐F2‐2009‐223175

National Institutes of Health

Grant: CA128978

National Institutes of Health

Grant: U19 CA148065

Wellcome Trust

Grant: v203477/Z/16/Z

NCI NIH HHS

Grant: P50 CA116201

NCI NIH HHS

Grant: R01 CA047147

NCI NIH HHS

Grant: R35 CA253187

Intramural NIH HHS

Grant: Z01 ES049030

NCI NIH HHS

Grant: HHSN261201800015I

NCI NIH HHS

Grant: HHSN261201800016I

NIEHS NIH HHS

Grant: P30 ES010126

NCI NIH HHS

Grant: R01 CA128978

NCI NIH HHS

Grant: R01 CA163353

NCI NIH HHS

Grant: R01 CA177150

NCI NIH HHS

Grant: UM1 CA186107

Cancer Foundation Finland sr

Grant: 220031

NCI NIH HHS

Grant: HHSN261201800032I

CDC HHS

Grant: NU58DP006320

NCI NIH HHS

Grant: P30 CA033572

NCI NIH HHS

Grant: R01 CA054281

NCI NIH HHS

Grant: U01 CA176726

NCI NIH HHS

Grant: P50 CA058223

NCI NIH HHS

Grant: R01 CA047305

NCI NIH HHS

Grant: R01 CA063464

NCI NIH HHS

Grant: R01 CA192393

NCI NIH HHS

Grant: U01 CA098758

NCI NIH HHS

Grant: U01 CA164973

NCI NIH HHS

Grant: U01 CA179715

NCI NIH HHS

Grant: U01 CA199277

NCI NIH HHS

Grant: U19 CA148112

Cancer Research UK

Grant: 25514

Medical Research Council

Grant: MR/M012190/1

NCI NIH HHS

Grant: P30 CA023100

NCI NIH HHS

Grant: R01 CA069664

NCI NIH HHS

Grant: UM1 CA176726

Medical Research Council

Grant: G1000143

NCI NIH HHS

Grant: P01 CA087969

NCI NIH HHS

Grant: P30 CA042014

NCI NIH HHS

Grant: R01 CA058860

NCI NIH HHS

Grant: R01 CA077398

NCI NIH HHS

Grant: R01 CA128931

NCI NIH HHS

Grant: R01 CA132839

NCI NIH HHS

Grant: R01 CA176785

NCI NIH HHS

Grant: U01 CA164920

NCI NIH HHS

Grant: UM1 CA164917

NCI NIH HHS

Grant: UM1 CA164920

NCI NIH HHS

Grant: K07 CA092044

NCCDPHP CDC HHS

Grant: NU58DP006344

Cancer Research UK

Grant: DRCPGM\100071

NCI NIH HHS

Grant: HHSN261201800009I

NCI NIH HHS

Grant: P30 CA008748

NCI NIH HHS

Grant: R01 CA097396

NCI NIH HHS

Grant: R01 CA116167

NCI NIH HHS

Grant: R01 CA140286

NCI NIH HHS

Grant: U19 CA148537

NCI NIH HHS

Grant: U54 CA156733

Intramural NIH HHS

Grant: Z01 CP010119

Canadian Institutes of Health Research

Grant: unidentified

unidentified

European Commission

Grant: 223175

Collaborative Oncological Gene-environment Study

Government of Canada

Fondation du cancer du sein du Québec

Wellcome Trust

Genome Canada

Wellcome Trust

FWCI

2.17

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.6272

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.6272

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.6272

journalhttps://doi.org/10.1002/cam4.6272

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37401034

Fields of Study

BRCA gene mutations in cancerBreast Cancer Treatment StudiesMale Breast Health Studies03 medical and health sciences0302 clinical medicineFemaleHumansBreast NeoplasmsCheckpoint Kinase 2Genetic Predisposition to DiseaseGerm-Line MutationHeterozygoteProportional Hazards Models

MeSH Terms

Breast NeoplasmsFemaleHeterozygoteHumansProportional Hazards ModelsGerm-Line MutationGenetic Predisposition to DiseaseCheckpoint Kinase 2

Keywords

Breast cancerMedicineOncologyInternal medicineRadiation therapySystemic therapyCancerSurvivalRadiotherapySystemic TreatmentContralateral Breast Cancer RiskChek2 C.1100delc Germline Genetic Variant

Sustainable Development Goals

SDG 0: Good health and well-being